Admission biomarkers among patients with acute myocardial-infarction related cardiogenic shock with or without out-of-hospital cardiac arrest an exploratory study

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Acute Heart Infarction 100%
• Out of Hospital Cardiac Arrest 100%
• Cardiogenic Shock 100%
• Neutrophil Gelatinase Associated Lipocalin 27%
• Lactic Acid 27%
• Carcinogenicity 27%
• Thrombomodulin 27%
• ST Segment Elevation Myocardial Infarction 9%
• Atrial Natriuretic Factor 9%
• Syndecan 1 9%
• Copeptin 9%
• Proadrenomedullin 9%

Keyphrases

• Acute Myocardial Infarction 100%
• Out-of-hospital Cardiac Arrest 100%
• Cardiogenic Shock 100%
• Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) 27%
• Lactate 27%
• Thrombomodulin 27%
• Soluble Suppression of Tumorigenicity 2 (sST2) 27%
• 30-day Mortality 18%
• Clinical Entities 18%
• ST-elevation Myocardial Infarction (STEMI) 9%
• Adjusted Analysis 9%
• Atrial Natriuretic Peptide 9%
• Coronary Angiography 9%
• Two-level 9%
• Acute Coronary Event 9%
• Syndecan-1 9%
• Shock Patient 9%
• Copeptin 9%
• Blood-borne 9%
• MR-proADM 9%

Biochemistry, Genetics and Molecular Biology

• Cardiac Arrest 100%
• Lipocalin 27%
• Gelatinase 27%
• Thrombomodulin 27%
• ST Elevation 9%
• Atrial Natriuretic Peptide 9%
• Syndecan 1 9%
• Copeptin 9%
• Potential Difference 9%